Arcus Biosciences, Inc. - COM (RCUS)

Historical Portfolio Holders from Q1 2018 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
51.8 M
Holdings value Q1 2024
$978 M
Value change Q1 2024
-$3.96 M
Grand Portfolio weight change Q1 2024
0%
Number of holders
162
Number of buys Q1 2024
74
Number of sells Q1 2024
-84
Average buys Q1 2024 %
+0%
Average sells Q1 2024 %
-0.001%
CUSIP
03969F109
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 51.8 M $978 M -$3.96 M $18.88 162
2023 Q4 52 M $993 M -$14.5 M $19.10 179
2023 Q3 52.4 M $940 M -$31.1 M $17.95 180
2023 Q2 54.1 M $1.1 B -$12.8 M $20.31 173
2023 Q1 55.3 M $1.01 B +$18 M $18.24 174
2022 Q4 53.7 M $1.11 B +$35.4 M $20.68 196
2022 Q3 50.8 M $1.33 B -$628 K $26.16 162
2022 Q2 52.3 M $1.33 B +$7.69 M $25.34 158
2022 Q1 49.8 M $1.57 B -$27.8 M $31.56 143
2021 Q4 50.8 M $2.06 B +$106 M $40.47 136
2021 Q3 48.3 M $1.68 B +$59.9 M $34.87 126
2021 Q2 45.1 M $1.24 B +$11.6 M $27.46 128
2021 Q1 44.7 M $1.25 B +$5.08 M $28.08 144
2020 Q4 44.1 M $1.15 B +$12.2 M $25.96 140
2020 Q3 43.8 M $751 M +$13.2 M $17.14 123
2020 Q2 41.8 M $1.03 B +$375 M $24.74 136
2020 Q1 27 M $374 M +$109 K $13.88 86
2019 Q4 27.1 M $274 M -$3.03 M $10.10 73
2019 Q3 25.8 M $235 M -$570 K $9.10 70
2019 Q2 26.4 M $210 M +$6.13 M $7.95 73
2019 Q1 25.8 M $322 M -$12.8 M $12.49 60
2018 Q4 26.9 M $289 M -$5.15 M $10.77 61
2018 Q3 22.4 M $313 M +$920 K $13.94 53
2018 Q2 22.4 M $274 M +$32.1 M $12.24 59
2018 Q1 16.3 M $251 M +$251 M $15.44 55